Sedivention

Sedivention is a Germany-based medtech startup focused on developing a minimally invasive, one-time outpatient therapy for the treatment of obesity. Their approach utilizes a targeted cryo procedure delivered via a specially designed balloon catheter to interrupt hunger-related signals in the vagus nerve. This aims to address the underlying physiological mechanisms of obesity and enable sustained appetite reduction without surgery, implants, or ongoing medication. The company has developed a functional prototype and plans to advance product development, conduct a first-in-human study, and prepare for regulatory and market entry.